The Nexus of Innovation: Analyzing IRC Section 174 Capitalization and the Kansas R&D Tax Credit

IRC Section 174 mandates that companies must spread out (amortize) their research and development expenses over five years for federal tax purposes, significantly altering taxable income. In Kansas, this federal amortization requirement is generally adopted for state income calculation, but the separate Kansas R&D tax credit (10% of incremental qualified costs) provides a vital offset for innovation performed within the state.

The federal mandatory capitalization requirement imposed by the Tax Cuts and Jobs Act (TCJA) has drastically increased the immediate taxable income base for R&D businesses. Because Kansas largely conforms to Federal Taxable Income (FTI) as its starting point for state tax calculation (K.S.A. 79-32,138(a)), this federal increase translates directly into a higher state tax liability. The Kansas R&D tax credit, enhanced post-2022 with a 10% rate and transferability, serves as the critical mitigation strategy, yet its calculation relies on the significantly narrower definition of Qualified Research Expenses (QREs) under IRC Section 41, creating a permanent structural conflict between the tax base and the incentive mechanism.

II. The Federal Tax Landscape: IRC Section 174 Mechanics and Scope

The accounting treatment of research expenditures for tax purposes is governed by Internal Revenue Code (IRC) Section 174, which experienced a profound shift for tax years beginning after December 31, 2021.1 This mandate dictates the initial tax base that Kansas adopts.

2.1 The Capitalization Mandate (Post-TCJA 2022)

The most critical change under the TCJA was the transition from optional immediate expensing to mandatory capitalization of Specified Research or Experimental (SRE) expenditures. This eliminated the ability for businesses to deduct these costs fully in the year they were incurred, forcing them instead into amortization.1

The length of the amortization period depends on where the research is conducted:

  • Domestic R&E: Expenditures must be amortized ratably over a five-year period.3 The amortization period begins at the midpoint of the taxable year in which the expenditures were paid or incurred.5
  • Foreign R&E: Consistent with the TCJA, foreign R&E expenditures must be amortized over a much longer 15-year period.3

Furthermore, IRC Section 174(d) imposes a rigid treatment regarding asset life. If any property associated with SRE expenditures is disposed of, retired, or abandoned during the amortization period, no immediate deduction or reduction to the amount realized is allowed. Instead, the amortization of the SRE expenditures must continue for the remainder of the applicable five- or fifteen-year period.5 This stringent rule emphasizes the long-term tax commitment inherent in the capitalization requirement.

The procedural implementation of these rules is considered a mandatory change in method of accounting, applied on a cut-off basis—meaning only post-2021 expenditures are affected, and no IRC Section 481(a) adjustment is necessary.5 The IRS has provided administrative relief through guidance such as Revenue Procedure 2023-8, which, for some years, simplified the required accounting method change from filing Form 3115 to submitting an explanatory statement.6 It is important to note that ongoing legislative proposals (such as the One Big Beautiful Bill Act, or OBBBA) aim to retroactively restore full expensing for domestic R&E costs for tax years 2022 through 2024, which would require careful planning for transition rules if enacted.3

2.2 Defining Allowable Expenses Under IRC 174

IRC Section 174 defines SRE expenditures broadly, covering costs related to the development or improvement of a product, process, formula, invention, or software.8

Inclusions: Allowable expenses that are subject to mandatory capitalization include costs directly related to R&E activities:

  • Labor: Wages paid to employees performing or directly supervising R&D activities.2
  • Supplies: Materials and supplies used or consumed in the research or experimental process.2
  • Contract Research: Costs paid to third parties for outsourced research services.2
  • Indirect Costs: Overhead and other costs that are directly related to the R&D activities.8
  • Software Development: Notably, post-2021, any amount paid or incurred in connection with the development of software is explicitly treated as a research or experimental expenditure subject to capitalization.2

Exclusions: Expenditures for the acquisition or improvement of land, or for property that is subject to depreciation (Section 167) or depletion (Section 611) are excluded from the IRC 174 capitalization pool. However, the allowances for depreciation or depletion associated with that property, when used in R&E activities, must themselves be treated as R&E expenditures and capitalized.7

2.3 The Critical Distinction: IRC 174 Capitalization Base vs. IRC 41 Credit Base

For tax planning in Kansas, it is vital to recognize that the scope of expenditures subject to capitalization under IRC 174 is significantly broader than the Qualified Research Expenses (QREs) eligible for the R&D tax credit under IRC Section 41.9

The IRC 41 credit base focuses on direct costs such as wages, materials, supplies, and a portion (65%) of contract research.9 Conversely, the IRC 174 capitalization base is more expansive, encompassing both direct and allocable indirect costs, such as overhead and certain legal fees (e.g., patent filing costs).4

This divergence creates a tax base mismatch: the capitalization requirement increases taxable income based on a large, inclusive pool of costs, yet the state tax credit mechanism designed to mitigate that increase is calculated based on a narrower, less inclusive pool. Consequently, businesses must track and allocate indirect costs to the IRC 174 amortization schedule even though these costs contribute no value toward the calculation of the Kansas R&D tax credit.9 This structural difference ensures that the negative impact of federal capitalization is often calculated based on a larger expense pool than the positive offset provided by the state credit.

Table 1: Scope Comparison: IRC 174 SREs vs. IRC 41 QREs

Expenditure Type IRC 174 (Capitalization Base) IRC 41 (Credit Base)
Wages (Direct Research Labor) Included 8 Included 9
Supplies Used in Research Included 8 Included 9
Contract Research (Third-Party) Included (100% Capitalized) 8 Limited (65% Eligible) 9
Overhead/Indirect Costs Included 8 Excluded 9
Legal Fees (e.g., Patent Filing) Included Excluded 9
Software Development Costs Explicitly Included 7 Included (If meet 4-part test) 2

III. Kansas State Conformity and Taxable Income Calculation

The application of IRC 174 in Kansas is determined by the state’s conformity laws, which require R&D businesses to adopt the federal amortization schedule for state income purposes.

3.1 Statutory Conformity to Federal Taxable Income

Kansas state law establishes a direct linkage to federal tax figures. K.S.A. 79-32,138(a) mandates that the Kansas taxable income of a corporation shall be the corporation’s federal taxable income for the taxable year, subject only to specific state modifications.11

Since Kansas utilizes Federal Taxable Income (FTI) as its starting point, the state automatically conforms to the mandatory capitalization and amortization rules of IRC Section 174.12 If a business is required to capitalize and amortize R&E costs over five years for federal tax calculation, that reduced federal deduction is reflected in a higher FTI, and consequently, a higher starting point for calculating Kansas corporate income tax.11 Unlike some jurisdictions, Kansas has not enacted specific “decoupling” provisions to allow R&E costs to be immediately expensed for state tax purposes, thus solidifying the application of the amortization mandate within the state.13

3.2 Financial Impact on Kansas Taxpayers

The direct financial consequence of this conformity is a significant and often involuntary acceleration of state income tax liability, particularly for R&D-intensive firms.

By requiring R&E costs to be capitalized and amortized over five years, the immediate deduction available to a taxpayer is severely limited—for example, only 10% of domestic costs are deductible in the first year.6 This delayed deduction substantially inflates the current-year FTI, a phenomenon known as “Tax Base Inflation.” This inflation flows directly through to the Kansas income calculation, creating an artificially high state tax base in the early years of a research project, regardless of whether the business is generating net profits.9

The imposition of this non-cash tax event is highly detrimental to growing businesses, especially those utilizing Net Operating Losses (NOLs), as it transforms large, beneficial R&D investments into a current-year tax burden.9 The need to manage this cash flow disruption means that the Kansas R&D tax credit is not merely an incentive but a critical tool necessary to mitigate the state tax liability generated by the conformity rules.

IV. The Enhanced Kansas R&D Tax Credit (K.S.A. 79-32,182b)

The Kansas Research and Development tax credit, authorized under K.S.A. 79-32,182b, serves as the state’s primary mechanism to encourage R&D investment and counteract the unfavorable tax consequences of the IRC 174 mandatory capitalization.

4.1 Eligibility and Qualification Standards

To claim the Kansas credit, expenditures must meet the federal standard of Qualified Research Expenses (QREs) as defined under IRC Section 41.14 This necessitates that the underlying activities satisfy the four-part test for qualified research, which requires activities to be technological in nature, aimed at eliminating uncertainty, involving a process of experimentation, and related to a qualified business component.16

Additionally, the credit is strictly limited to R&D activities conducted within the State of Kansas.14

A significant expansion of eligibility took effect for tax years beginning after December 31, 2022. Under the previous regime, the credit was often limited in scope. The new legislation made the R&D credit available to all eligible taxpayers, specifically including personal income taxpayers and pass-through entities (such as S corporations and partnerships), thereby expanding the incentive to small and mid-sized businesses that often utilize these structures.15

4.2 Credit Calculation Methodology

Kansas utilizes an incremental calculation methodology, rewarding businesses that increase their R&D investment over a historical base period.

The credit is calculated as a percentage of the difference between the actual qualified research and development expenses (QREs) for the current tax year and the average of the QREs for the current year and the two preceding tax years.14

  • Credit Rate: For taxable years commencing after December 31, 2022, the credit rate was increased from 6.5% to 10% of the incremental amount.14
  • Formula: The calculation determines the excess QREs:

    $$\text{Excess QREs} = \text{Current Year QREs} – \frac{(\text{Current Year QREs} + \text{Year} – 1 \text{ QREs} + \text{Year} – 2 \text{ QREs})}{3}$$
    $$\text{Credit Earned} = 10\% \times \text{Excess QREs}$$
    18

For businesses with no prior QREs, the three-year average calculation treats the base amount as one-third of the current year’s QREs, effectively making two-thirds (approximately 66.7%) of the first year’s QREs creditable.18

4.3 Kansas Department of Revenue (KDOR) Guidance and Procedures

To properly claim the credit, taxpayers must adhere to specific Kansas Department of Revenue (KDOR) procedural requirements. The credit is claimed using Schedule K-53.15 Furthermore, recent changes require taxpayers to complete and submit Form K-204, the Research and Development Credit Application, prior to claiming the credit on their return, unlike in prior years where a separate application was not mandatory.19

One of the most powerful features of the enhanced credit is the introduction of transferability for tax years commencing after December 31, 2022. The full credit may be transferred one time to another person, who can then claim it against their own Kansas income tax liability.15 This transformational provision provides critical liquidity to early-stage or cash-constrained R&D companies, enabling them to monetize the credit immediately and directly offsetting the cash burden created by the mandatory IRC 174 capitalization.19

Any remaining unused credit may be carried forward for utilization in subsequent years in 25% increments until the total amount of the credit is used.15

V. Integrated Case Study: IRC 174 Amortization and Kansas R&D Credit Calculation

This integrated example demonstrates how a Kansas-based company handles both the tax base increase from IRC 174 conformity and the offsetting benefit from the Kansas R&D tax credit.

5.1 Scenario Setup

A Kansas manufacturer of robotics equipment experienced consistent growth in its R&D activities. Assume that the broader pool of IRC 174 SREs paid or incurred annually totaled $1,000,000, while the narrower IRC 41 QREs utilized for the credit calculation were: $650,000 (2021), $900,000 (2022), and $1,300,000 (2023).20

5.2 Step 1: Mandatory IRC 174 Capitalization Impact on Kansas Taxable Income

Since Kansas conforms to FTI, the company must capitalize its $1,000,000 annual SREs over five years, commencing at the midpoint of the year.

Table 3: IRC 174 Capitalization Impact on Kansas Taxable Income

Year Total Domestic SREs IRC 174 Amortization Deduction Immediate Expense Forgone (Taxable Income Increase)
2022 $1,000,000 $100,000 (0.5 year deduction) $900,000
2023 $1,000,000 $300,000 ($200K from Y1 + $100K from Y2) $700,000

The company’s Kansas taxable income is artificially inflated by $1.6 million over just two years due to the mandated delay in R&E deduction. This forced increase in the state tax base creates the need for strategic mitigation.

5.3 Step 2: Determining the Kansas R&D Credit Earned

The company calculates its incremental R&D credit using the Kansas QRE base (IRC 41 criteria) and the historical three-year average, applying the appropriate credit rate (6.5% for 2021, 10% thereafter).14

Table 4: Multi-Year Kansas R&D Credit Calculation Example

Year Kansas QREs (A) Prior Year QREs (Y-1 / Y-2) 3-Year Average Base (B) Excess QREs (A – B) Credit Rate Kansas Credit Earned
2021 $650,000 $450,000 / $400,000 $500,000 $150,000 6.5% $9,750
2022 $900,000 $650,000 / $450,000 $666,667 $233,333 10.0% $23,333
2023 $1,300,000 $900,000 / $650,000 $950,000 $350,000 10.0% $35,000
Total (2022–2023) $2,200,000 $58,333

Note: The calculated credit figures align closely with data demonstrating a total of $61,000 in Kansas credits earned from 2020 through 2023.20

5.4 Financial Synthesis: Disparity and Mitigation

The case study illustrates the profound financial tension. In 2022, the IRC 174 mandate increased the company’s taxable income by $900,000, yet the resulting Kansas R&D tax credit was only $23,333. Similarly, in 2023, a $700,000 increase in taxable income was offset by a $35,000 credit.

This calculation confirms that, while the R&D tax credit is a dollar-for-dollar reduction of tax liability, its magnitude is generally insufficient to fully neutralize the state tax burden created by the massive, simultaneous increase in the state tax base due to IRC 174 conformity. This disparity reinforces the necessity of leveraging the transferability of the Kansas credit to manage liquidity and cover the tax liability arising from the nondeductible R&D expenses.

VI. Conclusion and Strategic Recommendations

The confluence of mandatory IRC Section 174 capitalization and Kansas’s conformity statute presents a complex tax planning environment. Kansas-based R&D companies must manage two distinct accounting challenges: inflating the tax base through capitalization (IRC 174) and generating a partial offset through the incremental credit calculation (IRC 41).

6.1 Strategic Mitigation

For businesses engaged in significant R&D, two mitigation strategies are paramount:

  1. Credit Monetization via Transferability: The introduction of transferability for the 10% Kansas R&D tax credit after 2022 is the most crucial financial mechanism available to counter the cash flow demands imposed by IRC 174.19 Companies facing large, non-cash tax increases can immediately sell the generated credit to third parties, providing essential working capital or covering the inflated state tax liability.
  2. Maximizing Incremental QREs: Since the Kansas credit is incremental, sustained growth in Kansas-apportioned QREs (meeting the IRC 41 standards) must be a core business objective.18 Only consistent, verifiable investment in R&D activities within the state will generate sufficient incremental credits to provide a meaningful offset.

6.2 Documentation Imperatives

Rigorous documentation is non-negotiable for dual compliance:

  1. Segregation of Expense Pools: Taxpayers must maintain meticulous records capable of accurately distinguishing between the two distinct pools of costs: the broad IRC 174 Specified Research or Experimental Expenditures (including overhead and indirect costs) required for the amortization schedule, and the narrower IRC 41 Qualified Research Expenses (excluding overhead and limiting contract research) required for the credit calculation.9 Audits require verifiable proof for both compliance regimes.
  2. KDOR Procedural Compliance: Compliance with the KDOR’s application requirements, including filing Form K-204 prior to claiming the credit on Schedule K-53, ensures the eligibility and validation process runs smoothly.17

6.3 Future Legislative Outlook

The tax position of Kansas R&D entities remains sensitive to federal legislative action. If Congress passes pending legislation, such as the retroactive reinstatement of full domestic IRC 174 expensing for 2022–2024, the tax landscape would immediately shift.3 Given Kansas’s conformity statute (K.S.A. 79-32,138(a)), such a federal change would necessitate the filing of amended Kansas returns to claim the immediate deduction, resulting in tax refunds or overpayments for the affected years. Prudent taxpayers must model these scenarios to maintain readiness for rapid tax adjustments.


Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

directive for LBI taxpayers

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars

Choose your state

find-us-map